5th TCR-based Therapies for Solid Tumors Summit 2024
Evvnt Promotion / evvnt
Archivio
23.04.2024 - 25.04.2024Hilton Boston Back Bay, 40 Dalton Street, 02115 Boston, Massachusetts, USA
Time: 9:00 AM - 5:30 PM
Temi della conferenza Our core commitment centers on advancing R and D and Clinical Development strategies for TCR therapies, aiming to harness their immense potential in targeting solid tumors. These therapies offer promising avenues for enhancing treatment methodologies, thereby fostering optimism for improved outcomes among patients grappling with these challenging conditions.
Speakers: Alfred Lim, Head of Pipeline Research, Etcembly, Andrew Bayliffe, Chief Scientific Officer, Marengo Therapeutics, Cagan Gurer, Vice President Disovery, TScan Therapeutics, and more